MAP2K5 (mitogen-activated protein kinase kinase 5, also known as MEK5) has been associated with various diseases including cardiovascular diseases, cancers, and central nervous system disorders (Appari et al., 2017; Liu et al., 2017; Castro et al., 2019). This evidence concerns the gene MAP2K5 and cardiovascular disorder.